lactulose has been researched along with Hepatitis, Chronic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carbonara, V; Cariello, R; Cartenì, M; Del Vecchio Blanco, C; Esposito, P; Federico, A; Loguercio, C; Martorelli, L; Miranda, A; Palasciano, G; Portincasa, P; Sapone, A; Scialdone, VR; Tiso, A; Tuccillo, C | 1 |
Fischer, R; Kalk, JF; Müting, D; Winter, G | 1 |
Holovach, IIu; Mytnyk, ZM; Neĭko, IeM | 1 |
3 other study(ies) available for lactulose and Hepatitis, Chronic
Article | Year |
---|---|
Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage.
Topics: Adult; Age Factors; Aged; Alcoholism; Case-Control Studies; Diabetes Complications; Female; Hepatitis, Chronic; Humans; Hypertension, Portal; Interleukin-6; Intestinal Absorption; Lactulose; Liver Cirrhosis; Male; Mannitol; Middle Aged; Nitrites; S-Nitrosothiols; Tumor Necrosis Factor-alpha | 2010 |
Treatment of chronic active hepatitis--present state.
Topics: Biopsy, Needle; Diet Therapy; Glutamate Dehydrogenase; Hepatitis, Chronic; Humans; L-Iditol 2-Dehydrogenase; Lactulose; Liver; Physical Exertion; Prognosis; Transaminases | 1984 |
[Different therapeutic approaches for chronic diffuse liver lesions using ornicetil, lactulose, etimizol and corinfar].
Topics: Etimizol; Hepatic Encephalopathy; Hepatitis, Chronic; Humans; Lactulose; Liver Cirrhosis; Liver Diseases; Middle Aged; Nifedipine; Ornithine; Treatment Outcome | 2002 |